Skip to main navigation Skip to search Skip to main content

Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES

  • ODYSSEY OUTCOMES Investigators†

Research output: Contribution to journalLetterpeer-review

10 Scopus citations
Original languageEnglish
Pages (from-to)448-451
Number of pages4
JournalJournal of the American College of Cardiology
Volume75
Issue number4
DOIs
StatePublished - Feb 4 2020

Fingerprint

Dive into the research topics of 'Sustained Low-Density Lipoprotein Cholesterol Lowering With Alirocumab in ODYSSEY OUTCOMES'. Together they form a unique fingerprint.

Cite this